Live Breaking News & Updates on Dexamethasone

Stay updated with breaking news from Dexamethasone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

#VisualAbstract: Adjunctive Dexamethasone for Tuberculous Meningitis in HIV-Positive Adults

Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute ....

Minute Medicine Inc , Tuberculous Meningitis ,

Gestational dexamethasone exposure impairs learning and memory function across generations

This new article publication from Acta Pharmaceutica Sinica B, discusses how gestational dexamethasone exposure impacts hippocampal excitatory synaptic transmission and learning and memory function with transgenerational effects. ....

Acta Pharmaceutica Sinica ,

Venetoclax Plus Dexamethasone Misses PFS End Point in t(11;14)+ R/R Multiple Myeloma

The combination of venetoclax and dexamethasone failed to significantly improve progression-free survival over pomalidomide plus dexamethasone in patients with t(11;14)-positive, relapsed or refractory multiple myeloma who have previously received at least 2 therapies. ....

San Diego , United States , Noord Holland , Venclexta Venclyxto , Mariana Cota Stirner , International Myeloma Working Group , European Hematology Association Congress , With Pomdex , Cota Stirner , Dimopoulosm A , Hematology Association Congress , Phase 3 Canova Study ,

Daratumumab Plus KRd With Tandem Transplant Sustains Efficacy in High-Risk, Newly Diagnosed Myeloma

Induction daratumumab, carfilzomib, lenalidomide, and dexamethasone followed by consolidation double transplant sustained efficacy and safety in patients with high-risk, newly diagnosed multiple myeloma. ....

Cyrille Touzeau , University Hospital Of Nantes , International Myeloma Society Annual Meeting , Department Of Hematology , Myeloma Society Annual , University Hospital , Multiple Myeloma ,

Inhaled fluticasone furoate falls flat in speeding up COVID-19 recovery, says ACTIV-6 trial

The ACTIV-6 trial investigated the effectiveness of inhaled fluticasone furoate on mild-to-moderate COVID-19 cases and found it did not accelerate recovery or prevent clinical progression compared to a placebo. Interestingly, vaccinated participants showed slightly faster recovery when treated with the drug, while unvaccinated participants did not. ....

United States , Fluticasone Furoate , New England Journal , Inhaled Fluticasone Furoate , Outpatient Treatment , Coronavirus Disease Covid 19 , Clinical Trial , Ars Cov 2 ,